These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24206567)

  • 1. Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals.
    Te Ao B; Brown P; Fink J; Vivian M; Feigin V
    Int J Stroke; 2015 Aug; 10(6):903-10. PubMed ID: 24206567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Ischemic Stroke (AIS) patient management in French stroke units and impact estimation of thrombolysis on care pathways and associated costs.
    Schmidt A; Heroum C; Caumette D; Le Lay K; Bénard S
    Cerebrovasc Dis; 2015; 39(2):94-101. PubMed ID: 25660476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
    Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
    Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study.
    Te Ao BJ; Brown PM; Feigin VL; Anderson CS
    Int J Stroke; 2012 Dec; 7(8):623-30. PubMed ID: 22010968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
    Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
    PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.
    Earnshaw SR; McDade C; Chapman AM; Jackson D; Schwamm L
    Clin Ther; 2012 Jul; 34(7):1544-58. PubMed ID: 22695225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis.
    Chiumente M; Gianino MM; Minniti D; Mattei TJ; Spass B; Kamal KM; Zimmerman DE; Muca A; Luda E
    Int J Stroke; 2015 Aug; 10(6):849-55. PubMed ID: 25854294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
    Leppert MH; Campbell JD; Simpson JR; Burke JF
    Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life costs and effects of an implementation program to increase thrombolysis in stroke.
    Dirks M; Baeten SA; Dippel DW; van Exel NJ; van Wijngaarden JD; Huijsman R; Koudstaal PJ; Niessen LW;
    Neurology; 2012 Aug; 79(6):508-14. PubMed ID: 22786601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of thrombolytic treatment for stroke.
    Mar J; Begiristain JM; Arrazola A
    Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
    Liberman AL; Choi HJ; French DD; Prabhakaran S
    Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke.
    Ganesalingam J; Pizzo E; Morris S; Sunderland T; Ames D; Lobotesis K
    Stroke; 2015 Sep; 46(9):2591-8. PubMed ID: 26251241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives.
    Switzer JA; Demaerschalk BM; Xie J; Fan L; Villa KF; Wu EQ
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):18-26. PubMed ID: 23212458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
    Earnshaw SR; Jackson D; Farkouh R; Schwamm L
    Stroke; 2009 May; 40(5):1710-20. PubMed ID: 19286581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.
    Lahr MM; van der Zee DJ; Luijckx GJ; Vroomen PC; Buskens E
    BMC Med Res Methodol; 2017 Jan; 17(1):5. PubMed ID: 28073360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.
    Kim AS; Nguyen-Huynh M; Johnston SC
    Stroke; 2011 Jul; 42(7):2013-8. PubMed ID: 21636817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.